Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04663347
Title Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

follicular lymphoma


Cisplatin + Cytarabine + Dexamethasone + Epcoritamab + Rituximab

Epcoritamab + Gemcitabine + Oxaliplatin

Epcoritamab + Lenalidomide + Rituximab

Bendamustine + Epcoritamab + Rituximab

Cyclophosphamide + Doxorubicin + Epcoritamab + Prednisone + Rituximab + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | BEL

No variant requirements are available.